Wound Closure Market Value to Surge at a Notable CAGR of 7.1% over 2025-2032; EziSurg Medical to Roll out easyEndoTM E-lite to Bolster its South American Foothold

The global wound closure market size stood at USD 14.19 billion in 2024. The market value is slated to rise from USD 15.10 billion in 2025 to USD 24.35 billion by 2032 at a CAGR of 7.1% during 2025-2032. Fortune Business Insights™ presents this information in its report titled “Wound Closure Market Size, Share & Industry Analysis, By Product Type (Sutures [Absorbable and Non-absorbable], Hemostatic Agents [Active Hemostats, Passive Hemostats, Combination Hemostats, and Others], Staplers [Powered and Manual], and Others), By Application (Orthopedics, Gynecology and Obstetrics, General Surgery, Ophthalmology, Cardiology, and Others), By End-User (Hospitals & ASCs, Specialty Clinics, and Others), and Regional Forecast, 2025-2032”.

According to the Journal of Orthopedic Case Reports, in 2021, the total number of joint replacements in India surged to 17,440 from 16,308 in 2020. Furthermore, in Portugal, nearly 42.3% individuals in the age group of 16 and above were recorded to have a chronic disorder or a long-standing health issue in 2024, according to Statistics Portugal. As the number of patient hospitalizations and surgical interventions takes an upward trajectory with the escalating prevalence of orthopedic disorders and chronic conditions, the demand for wound closure solutions is anticipated to increase globally. These solutions, which constitute the final step of surgical intervention, comprise hemostats, staplers, sutures, and other techniques for closing a wound and form a vital part of emergency medicine. A rise in trauma and accident cases is poised to open doors to new avenues for industry players.  

EziSurg Medical to Introduce easyEndoTM E-lite in Brazil to Consolidate Presence in South America

In September 2024, EziSurg Medical announced plans to launch easyEndo^TM E-lite powered endoscopic staplers in Brazil, expanding its presence in South America. The solution has emerged as a vital asset for the company, given that it holds more than 50% market share in the country. As announced by EziSurg, easyEndo^TM E-lite would be debuted at the October 2024 event CBCBM (Congresso Brasileiro de Cirurgia Bariátrica e Metabólica) in João Pessoa City.

Increase in Hospital Admissions Due to Rising Chronic Disease Prevalence to Fuel Industry Growth

The rising aging population and mounting prevalence of chronic disorders are driving a surge in the number of hospital admissions. The population in the age group of 60 and above is touted to rise from 1.00 billion in 2020 to 1.40 billion in 2030, as per the World Health Organization. An escalation in chronic conditions associated with aging is likely to propel the demand for wound closure products, pushing industry expansion.

Nevertheless, the high costs associated with R&D endeavors and innovation may hamper the adoption of these products, particularly in emerging countries such as Brazil, Poland, and China.

Health Conferences Emerge as a Key Platform for Market Players to Create Brand Awareness

Prominent players are emphasizing R&D activities to introduce novel products and consolidate their wound closure market share. Companies are also depicting an increased participation in medical events and health conferences to enhance consumer awareness of their products. Johnson & Johnson Services, Inc., and Medtronic are among the leading companies in the market.

Key Industry Developments

• September 2023 – Genesis MedTech, a key wound closure player, secured approval from China’s NMPA (National Medical Products Administration) for its absorbable sutures with antibacterial protection. The sutures have been claimed to be coated with triclosan, a broad-spectrum antimicrobial activity against gram-negative and gram-positive bacteria.

Key Players Profiled in the Report

• Johnson & Johnson Services, Inc. (U.S.)
• Baxter (U.S.)
• Medtronic (Ireland)
• Stryker (U.S.)
• Solventum (U.S.)
• Smith+Nephew (U.K.)
• B. Braun SE (Germany)
• Boston Scientific Corporation (U.S.)
• Frankenman International Ltd. (China)
• CooperSurgical Inc. (U.S.)
• Intuitive Surgical (U.S.)
• MANI, INC. (Japan)
• Artivion, Inc. (U.S.)
• CP Medical (Riverpoint Medical) (U.S.)
• CONMED Corporation (U.S.)
• Genesis Medtech (U.S.)

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/wound-closure-market-102630

Further Report Findings

• In 2024, North America led the global wound closure market with a valuation of USD 5.36 billion, favored by high spending on healthcare and the presence of established medical infrastructure. In the U.S., the market is anticipated to expand with the introduction of new products by key players.
• The Asia Pacific region is witnessing the soaring prevalence of diabetic foot ulcers and a rise in surgical procedures. The mounting geriatric population and increasing emphasis of industry players on securing regulatory approvals for launching new products are additional factors supporting wound closure market growth.
• The European market is poised to depict the second-largest CAGR over the analysis period, driven by rising government-led awareness initiatives emphasizing the use of antibiotic-induced sutures. Besides, the region records an escalating prevalence of chronic diseases, which fuels market expansion.

Table of Segmentation